Skip to main content

Table 4 Free parameters

From: Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action

Name

Description

Biological Range

Optimal Value

Reference

Slope %Syn

Slope of fraction of synapses disappearing/week

Max 0.075%/week, on top of neuronal loss

0.004

[94]

Slope %Neuron

Slope of neurons eliminated/week

Max 0.5%/week, leads to 50% neuron loss in 100 weeks

0.025

[78]

ACh deficit

Size of the cholinergic NBasalis deficit

Range 5-50% loss

0.175

[41, 95]

5-HT6 effect

Relation between 5-HT6 inhibition and

free DA, ACH and

NE increase

Maximum 0.20

0.025

[33]

DA increase in 12 wk placebo

DA surge from reward circuit that simulates placebo effect

Maximal 20% (tracer displacement in volunteers)

0.075

[42, 96]

Rel α 7 vs. α 4β 2 nACh-R effect

Relative effect of α7 over α 4β 2 nACh-R

mediated effects

Depends upon dose and nature of enhancement Range 0.4-2.0

2

[97]

AChE-I effect on M1 receptor activation

AChE-I increases M1 mACh-R activation level to make pyramidal cells more excitable

Maximal change in membrane resting potential -8 mV (depolarizing)

0.075/8 mg Gal or equiv

[98]

  1. List of 7 free parameters that were calibrated using the relation between clinical outcomes and working model outcomes. We report also the neurophysiological implementation and the biologically realistic boundaries, together with the value determined for the optimal correlation. With these 7 parameters on a database of 28 individual data points we achieve a correlation of r2 = 0.73.